Showing results (1131-1140 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|November 6, 2021
Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS studyMarco Garrido-Cumbrera, David Gálvez-Ruiz, Carlos J Delgado-Domínguez, et al.
RMD Open|December 4, 2021
Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in GermanyMadeline Deike, Ralph Brinks, Stephan Meller, et al.
RMD Open|December 4, 2021
Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case seriesTheerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, et al.
RMD Open|August 16, 2019
Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control studyAnna Ilar, Lars Klareskog, Saedis Saevarsdottir, et al.
RMD Open|August 16, 2019
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shiftKaterina Chatzidionysiou, Petros P Sfikakis
RMD Open|August 28, 2019
Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatmentMark C Genovese, Désirée van der Heijde, Yong Lin, et al.
RMD Open|August 28, 2019
ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritisHo Yin Chung, Eva Tsz Fung Chui, Kam Ho Lee, et al.
RMD Open|September 16, 2022
Is there a mitochondrial DNA haplogroup connection between osteoarthritis and elite athletes? A narrative reviewJohanne Martel-Pelletier, Jean-Pierre Pelletier
RMD Open|September 30, 2022
Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritisJonathan Kay, Amy E Bock, Muhammad Rehman, et al.
RMD Open|March 9, 2021
How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitatorsLaurette van Boheemen, Marieke M Ter Wee, Bart Seppen, et al.
Pageof 197